These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1974163)

  • 1. Assessing combination therapy in rheumatoid arthritis: treatment with sulphasalazine and penicillamine.
    Scott DL; Huskisson EC
    Br J Rheumatol; 1990 Aug; 29(4):313-4. PubMed ID: 1974163
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis.
    Taggart AJ; Hill J; Astbury C; Dixon JS; Bird HA; Wright V
    Br J Rheumatol; 1987 Feb; 26(1):32-6. PubMed ID: 2880632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.
    Situnayake RD; Grindulis KA; McConkey B
    Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy in rheumatoid arthritis.
    Farr M; Kitas GD; Bacon PA
    Br J Rheumatol; 1988 Feb; 27(1):73-4. PubMed ID: 2892558
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
    Borg AA; Davis MJ; Dawes PT; Shadforth MF
    Clin Rheumatol; 1994 Sep; 13(3):522-4. PubMed ID: 7835022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy in rheumatoid arthritis--study design.
    Fowler PD; Dawes PT; Sheeran TP; Shadforth MF
    Br J Rheumatol; 1987 Aug; 26(4):314-5. PubMed ID: 2886177
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of sulphasalazine on faecal flora in patients with rheumatoid arthritis: a comparison with penicillamine.
    Neumann VC; Shinebaum R; Cooke EM; Wright V
    Br J Rheumatol; 1987 Oct; 26(5):334-7. PubMed ID: 2889501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
    Farr M; Kitas G; Bacon PA
    Clin Rheumatol; 1988 Jun; 7(2):242-8. PubMed ID: 2901303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritis.
    Carroll GJ; Will RK; Breidahl PD; Tinsley LM
    Rheumatol Int; 1989; 8(6):251-5. PubMed ID: 2567049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphasalazine in rheumatoid arthritis: haematological problems.
    Lyle WH
    Br J Rheumatol; 1989 Aug; 28(4):363-4. PubMed ID: 2568148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rheumatoid arthritis developing into systemic lupus erythematosus during long-term treatment with penicillamine and sulfasalazine].
    Rejchrt S; Hrncír Z; Pintérová E
    Vnitr Lek; 1991 Jun; 37(6):597-603. PubMed ID: 1680256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in rheumatoid arthritis.
    Schwarzer AC; Arnold MH; Brooks PM
    Baillieres Clin Rheumatol; 1990 Dec; 4(3):663-85. PubMed ID: 1982708
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
    Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
    Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the response to gold or D-penicillamine by addition of sulphasalazine. A pilot study in 25 patients with rheumatoid arthritis.
    Dawes PT; Sheeran TP; Fowler PD; Shadforth MF
    Clin Exp Rheumatol; 1987; 5(2):151-3. PubMed ID: 2886241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.
    Farr M; Tunn E; Crockson AP; Bacon PA
    Clin Rheumatol; 1984 Dec; 3(4):473-81. PubMed ID: 6151882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of second line therapy in rheumatoid arthritis.
    Porter DR; McInnes I; Hunter J; Capell HA
    Ann Rheum Dis; 1994 Dec; 53(12):812-5. PubMed ID: 7864689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.